Research and clinical trials directly involving patients will have access to clinical settings and flexible workspaces at the new Royal Adelaide Hospital (RAH), according to Minister for Health, Jack Snelling.<\/p>\n\n\n\n
The Minister was responding to a letter from Hepatitis SA Executive Officer, Kerry Paterson, expressing concern over lack of space for clinical trials at the new RAH.<\/p>\n\n\n\n
In a letter dated 22 August, he said work was “underway to ensure that research and clinical trials groups operating at the current RAH will be relocated to the new RAH, or to appropriate accommodation within the South Australian Health and Biomedical Precinct<\/a>“. [Note: Link no longer available – replaced with Adelaide Biomed City<\/a><\/em>]<\/p>\n\n\n\n According to the SA Health website, the Health and Biomedical Precinct will be the largest in the southern hemisphere. The precinct the backbone of which are the new RAH the South Australian Health and Medical Research Institute (SAHMRI), will eventually include educational facilities and a focus on biomedical industries.<\/p>\n\n\n\n Minister Snelling said research and clinical trials are an integral part of modern patient treatment and will remain closely aligned and incorporated into clinical services at the new RAH.<\/p>\n\n\n\n